Suchergebnisse - "Rendell, Marc S."

PubPharm (27)

1

Albiglutide: a unique GLP-1 receptor agonist

enthalten in: Expert opinion on biological therapy | 2016

von Rendell, M.

2

Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial

enthalten in: Diabetologia | 2015

von Kothny, W. | Lukashevich, V. | Foley, J. | +2

3

DPP-4 inhibitors: focus on safety

enthalten in: Expert opinion on drug safety | 2015

von Tella, S. | Rendell, M.

4

Glucagon-like polypeptide agonists in type 2 diabetes mellitus: efficacy and tolerability, a balance

enthalten in: Therapeutic advances in endocrinology and metabolism | 2015

von Tella, S. | Rendell, M.

5

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

enthalten in: The journal of clinical investigation | 2015

von Rigby, M. | Harris, K. | Pinckney, A. | +24

6

Contraceptives and the Law: A View From a Catholic Medical Institution

enthalten in: The journal of the American Medical Association / Englische Ausgabe | 2013

von Zimmer, E. | Welie, J. | Rendell, M.

7

The effect of vasoactive agents on post-pressure hyperemia

enthalten in: Microvascular research | 2012

von Belzowzki, A. | Bergren, D. | Brugler, A. | +9

8

Insulin treatment of post-prandial hyperglycemia

enthalten in: Drug development research | 2008

von Rendell, M.

9

Targeting postprandial hyperglycemia

enthalten in: Metabolism: clinical and experimental | 2006

von Rendell, M. | Jovanovic, L.

10

Targeting postprandial hyperglycemia

enthalten in: Metabolism | 2006

von Rendell, M. | Jovanovic, L.